One of the mechanisms to explain the anticancer properties of LCn-3 PUFA involves the ability of these fatty acids to modulate the phosphorylation/activation of ERK1/2 and/or Akt and, in turn, the phosphorylation of multiple substrates involved in a variety of cellular responses and functions implicated in the development and progression of cancer. Here, MAPK3 is linked to cancer.